Schedule 13D ownership disclosure

TURNING POINT THERAPEUTICS I

Security class unavailable · CUSIP: 90041T108

Event date: 2019-04-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,992,550
Percent of class
6.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000903423-19-000202
Form type
SC 13D
Filer
GSK plc
CIK
CIK 1131399
Filed
Apr 26, 2019
Reporting period
Apr 22, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub